Top compounds associated with response to CCDC184


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.058 0.09
mRNA BAY 61-3606 GDSC1000 pan-cancer AAC -0.059 0.09
mRNA istradefylline CTRPv2 pan-cancer AAC -0.11 0.09
mRNA SNS-032 CTRPv2 pan-cancer AAC 0.063 0.09
mRNA LE-135 CTRPv2 pan-cancer AAC -0.065 0.09
mRNA apicidin CTRPv2 pan-cancer AAC -0.056 0.1
mRNA MG-132 GDSC1000 pan-cancer AAC -0.085 0.1
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.1
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC 0.058 0.1
mRNA Dasatinib GDSC1000 pan-cancer AAC -0.086 0.1
Download CSV